Interní Med. 2008; 10(11): 502-507

Chronic obstructive pulmonary disease nowadays

MUDr. Pavel Turčáni
Klinika nemocí plicních a tuberkulózy, FN Brno Bohunice

The article briefly discusses complex therapy, which is currently available for patients with COPD. It is based on pharmacological and nonpharmacological strategies. The emphasis is placed on basic characteristics of individual modalities and practical use of the presented knowledge in everyday practice.

Keywords: Key words: COPD, nonpharmacological therapy, pharmacological therapy, systemic inflammation.

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Turčáni P. Chronic obstructive pulmonary disease nowadays. Interní Med. 2008;10(11):502-507.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Journal of Respiratory and Critical Care Medicine 2006, 173: 1403. American Thoracic Society doi: 10.1164/rccm.200508-1211ST, American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation.
    2. Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912-919. Go to original source... Go to PubMed...
    3. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-1329. Go to original source... Go to PubMed...
    4. Debigar R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1712-1717. Go to original source... Go to PubMed...
    5. D'Urzo AD, De Salvo MC, Ramirez-Rivera A, et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, double-blind, within-patient, multicenter study. Chest 2001; 119: 1347-1356. Go to original source... Go to PubMed...
    6. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001; 56: 779-784. Go to original source... Go to PubMed...
    7. Hansel TT, Barnes PJ. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today 2002; 38: 585-600. Go to original source... Go to PubMed...
    8. Ito K, Lim S, Chung KF, Barnes PJ, Adcock IM. Theophylline enhances histone deacetylase activity and restores glucocorticoid function during oxidative stress. Am J Respir Crit Care Med 2002; 165: A625.
    9. Kawashima K, Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci 2003; 72: 2101-2109. Go to original source... Go to PubMed...
    10. Lederer DJ, Arcasoy SM. Update in surgical therapy for chronic obstructive pulmonary disease. Clin Chest Med 2007; 28: 639-653. Go to original source... Go to PubMed...
    11. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emfyzema. Report of the Medical research Council Working party. Lancet 1981, 1 (8222): 681-686.
    12. Mak JCW, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on down-regulation of pulmonary ß2-adrenergic receptors in vivo. J Clin Invest 1995; 96: 99-106. Go to original source... Go to PubMed...
    13. Mitrouska I, Tzanakis N, Siafakas NM. Oxygen therapy in chronic obstructive pulmonary disease. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Diease. Eur Respir Mon 2006; 38: 302-312. Go to original source...
    14. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1773-1777. Go to original source... Go to PubMed...
    15. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764. Go to original source... Go to PubMed...
    16. Plant PK, Owen JL, Parrott S, Elliott MW. Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. BMJ 2003; 326: 956. Go to original source... Go to PubMed...
    17. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156. Go to original source... Go to PubMed...
    18. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004; 24: 674-685. Go to original source... Go to PubMed...
    19. Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a doubleblind, placebo controlled, randomised trial. Lancet 2001; 357: 1571-1575. Go to original source... Go to PubMed...
    20. Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1090-1095. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.